Click for best price
Sepsis Biomarkers Market Size, Share 2023
Sepsis is an unusual systemic reaction to what is sometimes an otherwise ordinary infection, and it probably represents a pattern of response by the immune system to injury.
This report aims to provide a comprehensive presentation of the global market for Sepsis Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sepsis Biomarkers. This report contains market size and forecasts of Sepsis Biomarkers in global, including the following market information:
Global Sepsis Biomarkers Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Sepsis Biomarkers market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Blood Biomarkers Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Sepsis Biomarkers include Thermo Fisher Scientific, Merck, Bio-Rad Laboratories, QIAGEN, Roche, Danaher Corporation, Siemens Healthcare, Abbott and GenMark Diagnostics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Sepsis Biomarkers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sepsis Biomarkers Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Sepsis Biomarkers Market Segment Percentages, by Type, 2022 (%)
Blood Biomarkers
Urine Biomarkers
Global Sepsis Biomarkers Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Sepsis Biomarkers Market Segment Percentages, by Application, 2022 (%)
Diagnostics
Drug Discovery
Personalized Medicine
Others
Global Sepsis Biomarkers Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Sepsis Biomarkers Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sepsis Biomarkers revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Sepsis Biomarkers revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott
GenMark Diagnostics
HiMedia Laboratories
Immunexpress
Abionic
T2 Biosystems
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sepsis Biomarkers, market overview.
Chapter 2: Global Sepsis Biomarkers market size in revenue.
Chapter 3: Detailed analysis of Sepsis Biomarkers company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sepsis Biomarkers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Sepsis Biomarkers Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Sepsis Biomarkers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sepsis Biomarkers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sepsis Biomarkers Overall Market Size
2.1 Global Sepsis Biomarkers Market Size: 2022 VS 2030
2.2 Global Sepsis Biomarkers Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Sepsis Biomarkers Players in Global Market
3.2 Top Global Sepsis Biomarkers Companies Ranked by Revenue
3.3 Global Sepsis Biomarkers Revenue by Companies
3.4 Top 3 and Top 5 Sepsis Biomarkers Companies in Global Market, by Revenue in 2022
3.5 Global Companies Sepsis Biomarkers Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sepsis Biomarkers Players in Global Market
3.6.1 List of Global Tier 1 Sepsis Biomarkers Companies
3.6.2 List of Global Tier 2 and Tier 3 Sepsis Biomarkers Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Sepsis Biomarkers Market Size Markets, 2022 & 2030
4.1.2 Blood Biomarkers
4.1.3 Urine Biomarkers
4.2 By Type - Global Sepsis Biomarkers Revenue & Forecasts
4.2.1 By Type - Global Sepsis Biomarkers Revenue, 2018-2023
4.2.2 By Type - Global Sepsis Biomarkers Revenue, 2024-2030
4.2.3 By Type - Global Sepsis Biomarkers Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Sepsis Biomarkers Market Size, 2022 & 2030
5.1.2 Diagnostics
5.1.3 Drug Discovery
5.1.4 Personalized Medicine
5.1.5 Others
5.2 By Application - Global Sepsis Biomarkers Revenue & Forecasts
5.2.1 By Application - Global Sepsis Biomarkers Revenue, 2018-2023
5.2.2 By Application - Global Sepsis Biomarkers Revenue, 2024-2030
5.2.3 By Application - Global Sepsis Biomarkers Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Sepsis Biomarkers Market Size, 2022 & 2030
6.2 By Region - Global Sepsis Biomarkers Revenue & Forecasts
6.2.1 By Region - Global Sepsis Biomarkers Revenue, 2018-2023
6.2.2 By Region - Global Sepsis Biomarkers Revenue, 2024-2030
6.2.3 By Region - Global Sepsis Biomarkers Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Sepsis Biomarkers Revenue, 2018-2030
6.3.2 US Sepsis Biomarkers Market Size, 2018-2030
6.3.3 Canada Sepsis Biomarkers Market Size, 2018-2030
6.3.4 Mexico Sepsis Biomarkers Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Sepsis Biomarkers Revenue, 2018-2030
6.4.2 Germany Sepsis Biomarkers Market Size, 2018-2030
6.4.3 France Sepsis Biomarkers Market Size, 2018-2030
6.4.4 U.K. Sepsis Biomarkers Market Size, 2018-2030
6.4.5 Italy Sepsis Biomarkers Market Size, 2018-2030
6.4.6 Russia Sepsis Biomarkers Market Size, 2018-2030
6.4.7 Nordic Countries Sepsis Biomarkers Market Size, 2018-2030
6.4.8 Benelux Sepsis Biomarkers Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Sepsis Biomarkers Revenue, 2018-2030
6.5.2 China Sepsis Biomarkers Market Size, 2018-2030
6.5.3 Japan Sepsis Biomarkers Market Size, 2018-2030
6.5.4 South Korea Sepsis Biomarkers Market Size, 2018-2030
6.5.5 Southeast Asia Sepsis Biomarkers Market Size, 2018-2030
6.5.6 India Sepsis Biomarkers Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Sepsis Biomarkers Revenue, 2018-2030
6.6.2 Brazil Sepsis Biomarkers Market Size, 2018-2030
6.6.3 Argentina Sepsis Biomarkers Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Sepsis Biomarkers Revenue, 2018-2030
6.7.2 Turkey Sepsis Biomarkers Market Size, 2018-2030
6.7.3 Israel Sepsis Biomarkers Market Size, 2018-2030
6.7.4 Saudi Arabia Sepsis Biomarkers Market Size, 2018-2030
6.7.5 UAE Sepsis Biomarkers Market Size, 2018-2030
7 Sepsis Biomarkers Companies Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Sepsis Biomarkers Major Product Offerings
7.1.4 Thermo Fisher Scientific Sepsis Biomarkers Revenue in Global Market (2018-2023)
7.1.5 Thermo Fisher Scientific Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Sepsis Biomarkers Major Product Offerings
7.2.4 Merck Sepsis Biomarkers Revenue in Global Market (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Bio-Rad Laboratories
7.3.1 Bio-Rad Laboratories Company Summary
7.3.2 Bio-Rad Laboratories Business Overview
7.3.3 Bio-Rad Laboratories Sepsis Biomarkers Major Product Offerings
7.3.4 Bio-Rad Laboratories Sepsis Biomarkers Revenue in Global Market (2018-2023)
7.3.5 Bio-Rad Laboratories Key News & Latest Developments
7.4 QIAGEN
7.4.1 QIAGEN Company Summary
7.4.2 QIAGEN Business Overview
7.4.3 QIAGEN Sepsis Biomarkers Major Product Offerings
7.4.4 QIAGEN Sepsis Biomarkers Revenue in Global Market (2018-2023)
7.4.5 QIAGEN Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Sepsis Biomarkers Major Product Offerings
7.5.4 Roche Sepsis Biomarkers Revenue in Global Market (2018-2023)
7.5.5 Roche Key News & Latest Developments
7.6 Danaher Corporation
7.6.1 Danaher Corporation Company Summary
7.6.2 Danaher Corporation Business Overview
7.6.3 Danaher Corporation Sepsis Biomarkers Major Product Offerings
7.6.4 Danaher Corporation Sepsis Biomarkers Revenue in Global Market (2018-2023)
7.6.5 Danaher Corporation Key News & Latest Developments
7.7 Siemens Healthcare
7.7.1 Siemens Healthcare Company Summary
7.7.2 Siemens Healthcare Business Overview
7.7.3 Siemens Healthcare Sepsis Biomarkers Major Product Offerings
7.7.4 Siemens Healthcare Sepsis Biomarkers Revenue in Global Market (2018-2023)
7.7.5 Siemens Healthcare Key News & Latest Developments
7.8 Abbott
7.8.1 Abbott Company Summary
7.8.2 Abbott Business Overview
7.8.3 Abbott Sepsis Biomarkers Major Product Offerings
7.8.4 Abbott Sepsis Biomarkers Revenue in Global Market (2018-2023)
7.8.5 Abbott Key News & Latest Developments
7.9 GenMark Diagnostics
7.9.1 GenMark Diagnostics Company Summary
7.9.2 GenMark Diagnostics Business Overview
7.9.3 GenMark Diagnostics Sepsis Biomarkers Major Product Offerings
7.9.4 GenMark Diagnostics Sepsis Biomarkers Revenue in Global Market (2018-2023)
7.9.5 GenMark Diagnostics Key News & Latest Developments
7.10 HiMedia Laboratories
7.10.1 HiMedia Laboratories Company Summary
7.10.2 HiMedia Laboratories Business Overview
7.10.3 HiMedia Laboratories Sepsis Biomarkers Major Product Offerings
7.10.4 HiMedia Laboratories Sepsis Biomarkers Revenue in Global Market (2018-2023)
7.10.5 HiMedia Laboratories Key News & Latest Developments
7.11 Immunexpress
7.11.1 Immunexpress Company Summary
7.11.2 Immunexpress Business Overview
7.11.3 Immunexpress Sepsis Biomarkers Major Product Offerings
7.11.4 Immunexpress Sepsis Biomarkers Revenue in Global Market (2018-2023)
7.11.5 Immunexpress Key News & Latest Developments
7.12 Abionic
7.12.1 Abionic Company Summary
7.12.2 Abionic Business Overview
7.12.3 Abionic Sepsis Biomarkers Major Product Offerings
7.12.4 Abionic Sepsis Biomarkers Revenue in Global Market (2018-2023)
7.12.5 Abionic Key News & Latest Developments
7.13 T2 Biosystems
7.13.1 T2 Biosystems Company Summary
7.13.2 T2 Biosystems Business Overview
7.13.3 T2 Biosystems Sepsis Biomarkers Major Product Offerings
7.13.4 T2 Biosystems Sepsis Biomarkers Revenue in Global Market (2018-2023)
7.13.5 T2 Biosystems Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Sepsis Biomarkers Market Opportunities & Trends in Global Market
Table 2. Sepsis Biomarkers Market Drivers in Global Market
Table 3. Sepsis Biomarkers Market Restraints in Global Market
Table 4. Key Players of Sepsis Biomarkers in Global Market
Table 5. Top Sepsis Biomarkers Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Sepsis Biomarkers Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Sepsis Biomarkers Revenue Share by Companies, 2018-2023
Table 8. Global Companies Sepsis Biomarkers Product Type
Table 9. List of Global Tier 1 Sepsis Biomarkers Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sepsis Biomarkers Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Sepsis Biomarkers Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Sepsis Biomarkers Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Sepsis Biomarkers Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Sepsis Biomarkers Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Sepsis Biomarkers Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Sepsis Biomarkers Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Sepsis Biomarkers Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Sepsis Biomarkers Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Sepsis Biomarkers Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Sepsis Biomarkers Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Sepsis Biomarkers Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Sepsis Biomarkers Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Sepsis Biomarkers Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Sepsis Biomarkers Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Sepsis Biomarkers Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Sepsis Biomarkers Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Sepsis Biomarkers Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Sepsis Biomarkers Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Sepsis Biomarkers Revenue, (US$, Mn), 2024-2030
Table 30. Thermo Fisher Scientific Company Summary
Table 31. Thermo Fisher Scientific Sepsis Biomarkers Product Offerings
Table 32. Thermo Fisher Scientific Sepsis Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 33. Thermo Fisher Scientific Key News & Latest Developments
Table 34. Merck Company Summary
Table 35. Merck Sepsis Biomarkers Product Offerings
Table 36. Merck Sepsis Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 37. Merck Key News & Latest Developments
Table 38. Bio-Rad Laboratories Company Summary
Table 39. Bio-Rad Laboratories Sepsis Biomarkers Product Offerings
Table 40. Bio-Rad Laboratories Sepsis Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 41. Bio-Rad Laboratories Key News & Latest Developments
Table 42. QIAGEN Company Summary
Table 43. QIAGEN Sepsis Biomarkers Product Offerings
Table 44. QIAGEN Sepsis Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 45. QIAGEN Key News & Latest Developments
Table 46. Roche Company Summary
Table 47. Roche Sepsis Biomarkers Product Offerings
Table 48. Roche Sepsis Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Danaher Corporation Company Summary
Table 51. Danaher Corporation Sepsis Biomarkers Product Offerings
Table 52. Danaher Corporation Sepsis Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 53. Danaher Corporation Key News & Latest Developments
Table 54. Siemens Healthcare Company Summary
Table 55. Siemens Healthcare Sepsis Biomarkers Product Offerings
Table 56. Siemens Healthcare Sepsis Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 57. Siemens Healthcare Key News & Latest Developments
Table 58. Abbott Company Summary
Table 59. Abbott Sepsis Biomarkers Product Offerings
Table 60. Abbott Sepsis Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 61. Abbott Key News & Latest Developments
Table 62. GenMark Diagnostics Company Summary
Table 63. GenMark Diagnostics Sepsis Biomarkers Product Offerings
Table 64. GenMark Diagnostics Sepsis Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 65. GenMark Diagnostics Key News & Latest Developments
Table 66. HiMedia Laboratories Company Summary
Table 67. HiMedia Laboratories Sepsis Biomarkers Product Offerings
Table 68. HiMedia Laboratories Sepsis Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 69. HiMedia Laboratories Key News & Latest Developments
Table 70. Immunexpress Company Summary
Table 71. Immunexpress Sepsis Biomarkers Product Offerings
Table 72. Immunexpress Sepsis Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 73. Immunexpress Key News & Latest Developments
Table 74. Abionic Company Summary
Table 75. Abionic Sepsis Biomarkers Product Offerings
Table 76. Abionic Sepsis Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 77. Abionic Key News & Latest Developments
Table 78. T2 Biosystems Company Summary
Table 79. T2 Biosystems Sepsis Biomarkers Product Offerings
Table 80. T2 Biosystems Sepsis Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 81. T2 Biosystems Key News & Latest Developments
List of Figures
Figure 1. Sepsis Biomarkers Segment by Type in 2022
Figure 2. Sepsis Biomarkers Segment by Application in 2022
Figure 3. Global Sepsis Biomarkers Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Sepsis Biomarkers Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Sepsis Biomarkers Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Sepsis Biomarkers Revenue in 2022
Figure 8. By Type - Global Sepsis Biomarkers Revenue Market Share, 2018-2030
Figure 9. By Application - Global Sepsis Biomarkers Revenue Market Share, 2018-2030
Figure 10. By Type - Global Sepsis Biomarkers Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Sepsis Biomarkers Revenue Market Share, 2018-2030
Figure 12. By Application - Global Sepsis Biomarkers Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Sepsis Biomarkers Revenue Market Share, 2018-2030
Figure 14. By Region - Global Sepsis Biomarkers Revenue Market Share, 2018-2030
Figure 15. By Country - North America Sepsis Biomarkers Revenue Market Share, 2018-2030
Figure 16. US Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Sepsis Biomarkers Revenue Market Share, 2018-2030
Figure 20. Germany Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 21. France Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Sepsis Biomarkers Revenue Market Share, 2018-2030
Figure 28. China Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 32. India Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Sepsis Biomarkers Revenue Market Share, 2018-2030
Figure 34. Brazil Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Sepsis Biomarkers Revenue Market Share, 2018-2030
Figure 37. Turkey Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Sepsis Biomarkers Revenue, (US$, Mn), 2018-2030
Figure 41. Thermo Fisher Scientific Sepsis Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck Sepsis Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bio-Rad Laboratories Sepsis Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. QIAGEN Sepsis Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Roche Sepsis Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Danaher Corporation Sepsis Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Siemens Healthcare Sepsis Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Abbott Sepsis Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. GenMark Diagnostics Sepsis Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. HiMedia Laboratories Sepsis Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Immunexpress Sepsis Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Abionic Sepsis Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. T2 Biosystems Sepsis Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
